Ongoing Developments in Biologic Therapy



Summary

Quality-of-Life Issues in Psoriasis Patients

Influence of Psoriasis Treatment on Quality of Life

Quality-of-Life Measures in Psoriasis Patients

Summary

References

Ongoing Developments in Biologic Therapy


Registration benefits include:
Access to CME/CE programs and certification
Free subscription to Biologic Bulletin newsletter
Reminders of new CME/CE activities
REGISTER NOW

Expert Practice: Addressing Quality-of-Life Issues in Psoriasis: Impact of Biologic Agents
Addressing Quality-of-Life Issues in Psoriasis: Impact of Biologic Agents

Release date: October 2007
Expiration date: October 31, 2008

Estimated time to complete activity: 30 minutes

Sponsored by Curatio CME Institute LLC

Support for this activity has been provided through an educational grant from Genentech, Inc.

Activity Overview
In patients with psoriasis, quality-of-life (QOL) issues are a significant concern. Melodie S. Young, a nurse practitioner who practices at Modern Dermatology, a Baylor-Health Texas Affiliate in Dallas, was recently interviewed on the topic of QOL among psoriasis patients. In this Expert Practice, Ms. Young discusses the measurement tools used to assess QOL, how psoriasis negatively affects the lives of patients, and how successful treatment can improve QOL.

Target Audience
This activity has been designed to meet the educational needs of physicians and other health care professionals involved in the care of patients with psoriasis.

Learning Objectives
Upon completion of this activity, participants should be able to:
  • Identify QOL issues that affect psoriasis patients
  • Discuss the use of QOL measurements in clinical studies and clinical practice
  • Describe how treatment with biologic agents affects QOL in psoriasis patients

Faculty
Melodie Young, MSN, RN, A/NP-C
Nurse Practitioner
Modern Dermatology, a Baylor-Health Texas Affiliate
Adjunct Clinical Instructor
The University of Texas Arlington, Graduate School of Nursing
Dallas, Texas

Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period October 2007 to October 31, 2008, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.

Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

Disclosure
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:

Melodie S. Young, MSN, RN, A/NP-C has disclosed the following relevant financial relationship(s):

Speaker:       Abbott, Amgen, Coria Laboratories, Genentech, Stiefel Laboratories
Consultant:   Abbott, Amgen

Curatio CME Institute

Shari J. Dermer, PhD, Medical Director, has disclosed no relevant financial relationships.

Thomas F. Finnegan, PhD, Medical Writer, has disclosed no relevant financial relationships.

Brett Mutschler, CME Director, has disclosed no relevant financial relationships.

Jonathan S. Simmons, ELS, Managing Editor, has disclosed no relevant financial relationships.

Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.

Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Genentech, Inc. do not recommend the use of any agent outside the labeled indications.

The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Hardware/Software Requirements

  • Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher
  • If you are using a Mac computer system and are experiencing problems with your browser, we suggest downloading the latest version of Firefox for Mac
Contact Information
PsoriasisTx
100 Campbell Boulevard
Suite 103
Exton, PA 19341
editor@psoriasistx.com

Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME.

Curatio CME Institute does not require individuals to register to use PsoriasisTx; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.

Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced.

Information gathered through PsoriasisTx will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be destroyed.

Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx is used. This information helps Curatio determine the best strategies for improving PsoriasisTx and better meeting the needs of its users. This software does not identify individual users.

PsoriasisTx does not employ cookies or any other software that violates a user's privacy.

If you have any questions about PsoriasisTx or any Curatio CME Institute policies, you may contact us at editor@psoriasistx.com.

Thank you for using PsoriasisTx.




Begin CME Activity